Miller JS - Search Results

1

Recipient HLA-C Haplotypes and microRNA 148a/b Binding Sites Have No Impact on Allogeneic Hematopoietic Cell Transplantation Outcomes.

Hoff GA, Fischer JC, Hsu K, Cooley S, Miller JS, Wang T, Haagenson M, Spellman S, Lee SJ, Uhrberg M, Venstrom JM, Verneris MR. Hoff GA, et al. Among authors: miller js. Biol Blood Marrow Transplant. 2017 Jan;23(1):153-160. doi: 10.1016/j.bbmt.2016.09.028. Epub 2016 Oct 13. Biol Blood Marrow Transplant. 2017. PMID: 27746218 Free PMC article.

2

The generation of human natural killer cells from CD34+/DR- primitive progenitors in long-term bone marrow culture.

Miller JS, Verfaillie C, McGlave P. Miller JS, et al. Blood. 1992 Nov 1;80(9):2182-7. Blood. 1992. PMID: 1384796 Free article.

3

Differentiation of natural killer (NK) cells from human primitive marrow progenitors in a stroma-based long-term culture system: identification of a CD34+7+ NK progenitor.

Miller JS, Alley KA, McGlave P. Miller JS, et al. Blood. 1994 May 1;83(9):2594-601. Blood. 1994. PMID: 7513206 Free article.

4

Large scale ex vivo expansion and activation of human natural killer cells for autologous therapy.

Miller JS, Klingsporn S, Lund J, Perry EH, Verfaillie C, McGlave P. Miller JS, et al. Bone Marrow Transplant. 1994 Oct;14(4):555-62. Bone Marrow Transplant. 1994. PMID: 7532064

5

Hematopoietic growth factors for graft failure after bone marrow transplantation: a randomized trial of granulocyte-macrophage colony-stimulating factor (GM-CSF) versus sequential GM-CSF plus granulocyte-CSF.

Weisdorf DJ, Verfaillie CM, Davies SM, Filipovich AH, Wagner JE Jr, Miller JS, Burroughs J, Ramsay NK, Kersey JH, McGlave PB, et al. Weisdorf DJ, et al. Among authors: miller js. Blood. 1995 Jun 15;85(12):3452-6. Blood. 1995. PMID: 7540062 Free article. Clinical Trial.

6

Autologous activated natural killer cells suppress primitive chronic myelogenous leukemia progenitors in long-term culture.

Cervantes F, Pierson BA, McGlave PB, Verfaillie CM, Miller JS. Cervantes F, et al. Among authors: miller js. Blood. 1996 Mar 15;87(6):2476-85. Blood. 1996. PMID: 8630414 Free article.

7

Relapse after non-T-cell-depleted allogeneic bone marrow transplantation for chronic myelogenous leukemia: early transplantation, use of an unrelated donor, and chronic graft-versus-host disease are protective.

Enright H, Davies SM, DeFor T, Shu X, Weisdorf D, Miller W, Ramsay NK, Arthur D, Verfaillie C, Miller J, Kersey J, McGlave P. Enright H, et al. Blood. 1996 Jul 15;88(2):714-20. Blood. 1996. PMID: 8695820 Free article.

8

Low dose subcutaneous interleukin-2 after autologous transplantation generates sustained in vivo natural killer cell activity.

Miller JS, Tessmer-Tuck J, Pierson BA, Weisdorf D, McGlave P, Blazar BR, Katsanis E, Verfaillie C, Lebkowski J, Radford J Jr, Burns LJ. Miller JS, et al. Biol Blood Marrow Transplant. 1997 Apr;3(1):34-44. Biol Blood Marrow Transplant. 1997. PMID: 9209739 Clinical Trial.

9

Cytokine-primed bone marrow stem cells vs. peripheral blood stem cells for autologous transplantation: a randomized comparison of GM-CSF vs. G-CSF.

Weisdorf D, Miller J, Verfaillie C, Burns L, Wagner J, Blazar B, Davies S, Miller W, Hannan P, Steinbuch M, Ramsay N, McGlave P. Weisdorf D, et al. Biol Blood Marrow Transplant. 1997 Oct;3(4):217-23. Biol Blood Marrow Transplant. 1997. PMID: 9360784 Clinical Trial.

10

Natural killer (NK) cells are functionally abnormal and NK cell progenitors are diminished in granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cell collections.

Miller JS, Prosper F, McCullar V. Miller JS, et al. Blood. 1997 Oct 15;90(8):3098-105. Blood. 1997. PMID: 9376591 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,146 results

Search Page

Filters